Meningitis & Encephalitis Treatment
Meningitis & Encephalitis Treatment
Treatment in this condition is unusual in one respect: it begins before the diagnosis is confirmed , and that is deliberate rather than careless. In the two causes here that are measured in hours — bacterial meningitis and herpes simplex encephalitis — the cost of waiting for confirmation is larger than the cost of treating on suspicion, so the treatment is given at the point of suspicion and stopped later where the question has been answered rather than assumed. What follows depends entirely on which organism it turns out to be, and the range is wide: a course measured in days, a course measured in weeks, or a regimen measured in months with monitoring attached. This page sets out what is given and on what grounds, what each of the longer regimens commits a person to, what the complications are, and what the months afterwards consist of — which is the part most often left to a family to discover.
The first hours, and what cannot wait
What happens in the first hours decides more than anything that happens afterwards, and the order of it is worth having clearly because it is counter-intuitive to anyone who has been taught that diagnosis comes before treatment.
The order is: blood cultures drawn, then the first dose given, and these two happen without a gap between them. Where a lumbar puncture is safe on the criteria set out on the diagnosis page, it happens in the same window and the dose follows it. Where it is not safe, imaging happens first, the puncture is deferred, and the dose still goes in rather than waiting for either.
The sentence that gets lost in practice is the one about the scan. Computed tomography is not a reason to delay antibacterial therapy. It is a reason to defer a puncture. Those are different decisions, and conflating them is the single most expensive error available in this condition.
Three other things belong in the first hours and are not treatment in the usual sense. The level of consciousness is recorded rather than described, so that a change later is a measurement rather than an impression. The rash, if there is one, is said out loud on arrival, because it moves the hour and it makes this a household rather than an individual matter. And the close contacts are named, because in meningococcal disease their prophylaxis is part of the same episode rather than a separate errand.
Antibacterial therapy
Where bacterial meningitis is a possibility, antibacterial therapy is started before the organism is known and adjusted once it is. That is what the word empirical means here, and it is worth saying plainly because families frequently understand it to mean the doctors were unsure whether to treat.
The choice of agent is made on the age of the person and the immune state rather than on preference, because what is plausible differs by both. The organisms that are likely in a neonate are not the ones likely in an adolescent, and the ones likely in someone whose immune system is impaired by a medicine, a condition or HIV are not the ones likely in someone whose immune system is intact. Listeria is a standing consideration at the extremes of age, in pregnancy and in immunosuppression, and a regimen chosen without regard to it will not cover it.
What follows the first dose is adjustment rather than continuation by default: the organism is named where it can be, its sensitivities are obtained where they can be, and the regimen is narrowed rather than left broad. Where nothing is ever named, that is a finding to be recorded rather than smoothed over, and it changes what the follow-up has to say.
Where a corticosteroid is used, it is used to damp the inflammatory response provoked by organisms being killed, and it is given with or before the first dose rather than after it. It is not given in every case and not for every organism. Where it has not been given, the reason is a reasonable question rather than a challenge.
Each of these medicines has its own monitoring and its own risks, and each is discussed here as it sits in this pathway — what it is used for, what it requires while it is being given, and what its own adverse effects are. No agent is presented as one this hospital routinely holds. Any medicine recommended that is not given within this pathway is named at the outset, before any payment is discussed.
Antiviral therapy
Where encephalitis is a possibility, antiviral therapy covering herpes simplex virus is started at the point of suspicion, and the reason is specific rather than general: this is the one common cause of encephalitis with a medicine that works, and it works on a timetable that does not wait for a laboratory.
It is also the one where the imaging often makes the decision before the fluid does. The herpes form has a predilection for the temporal lobes and the structures of memory, and where magnetic resonance imaging shows that pattern the decision is made on the imaging rather than on a polymerase chain reaction result that takes longer to arrive.
The course is measured in weeks and is given in full, which is a sentence worth hearing at the beginning rather than discovering halfway through. Where it is stopped, it is stopped on an answer — a negative test taken at an appropriate time, in a person whose course and imaging do not fit — rather than on an impression that the person seems better. Stopping on an improvement in how someone looks is how a partially treated encephalitis is made.
The other antivirals in this space are fewer and narrower, and the honest statement is that for most viral encephalitides other than the herpes group there is no specific antiviral, and what is given is supportive care and the management of complications. Saying that plainly is better than implying a treatment exists. Where Japanese encephalitis is the question there is no specific antiviral either — which is precisely why the vaccine, rather than any medicine, is the item that changes the outcome.
Where the cause is not straightforwardly bacterial or viral
Three groups sit outside the acute bacterial and viral picture, and each changes the timetable rather than merely the prescription.
Tuberculous meningitis is treated with a prolonged antituberculous regimen, measured in months rather than weeks, with monitoring of liver function and of vision attached to it because the medicines require both. The length is part of the treatment rather than an inconvenience, and a family told at the outset is a family that completes it. Where raised pressure is part of the picture — and at the base of the brain it often is — the management of that pressure is a separate and parallel piece of work rather than a detail.
Cryptococcal and other fungal meningitis is treated with prolonged antifungal therapy, similarly measured in months, and with the management of the immune state alongside it rather than after it. Where the immune state is the reason the organism was there at all, treating the organism without addressing the state is treating the consequence twice.
Post-infectious autoimmune encephalitis is the third, and it is the one this page exists most to name. A person who has recovered from a viral encephalitis and then deteriorates weeks later is usually not having the infection again. They are having an immune response directed at the brain, triggered by the infection that has already cleared. It is treated with immunomodulation rather than with antivirals, and it belongs to its own pathway rather than to a second course of the same medicine. Recognising it is the whole of the task; the treatment is someone else's chapter.
The complications, and what is done about them
What follows is what the illness leaves behind and what is done about each, and the point of the list is that almost all of it is more usefully planned for than discovered.
| Complication | What it looks like | What it warrants |
|---|---|---|
| Hearing loss | Not hearing, asking for repetition, a television turned up, a phone held to one ear | Formal audiometry before discharge rather than at home. It is the one sequela where when it is found changes what can be done |
| Raised pressure, or hydrocephalus | A headache that returns, vomiting, a falling level of consciousness, or a gait that has changed | Imaging matched to the change, and the question of diversion asked rather than assumed. It is set out in the hydrocephalus pathway |
| Seizures, and epilepsy after it | A further seizure, or a period afterwards in which the person does not return to themselves | Electroencephalography where the consciousness does not match the picture, and a plan for what happens after a second event |
| Cognitive and behavioural change | Memory that is not what it was, a shorter fuse, tasks that take far longer than they did | Formal review at a defined interval rather than a general instruction. It is invisible on a scan and it is almost never asked about |
| A relapse weeks later | A second deterioration, usually with behaviour or movement rather than with fever | The autoimmune question first. Not a recurrence, and not treated with the same medicine |
| Fatigue and the loss of a former pace | A day that cannot be got through, and a recovery that is slower than the family was told to expect | Named as a consequence rather than as a failure of will, with a plan for building back rather than a deadline for it |
What should not happen is a discharge that answers only whether the infection cleared. The two rows that are most often missing from a plan are the first and the fourth, and they are the two that families live with longest.
What the months afterwards contain
The months after the acute illness are where this condition is actually lived, and they are the part most often left unstructured. Four things belong in a plan, each with an interval attached rather than a general instruction to keep an eye on it.
Audiology, before discharge where the illness was bacterial, and again where anything has changed since. Cognitive and behavioural review, at a defined interval, with the person's former baseline as the comparator rather than a population one — because the question is whether this person is back to themselves, not whether they are within a range. A question about relapse, asked explicitly at the review rather than assumed away: has anything gone backwards since the recovery, and if so, when. And rehabilitation, where there is something to rehabilitate: speech, swallowing, mobility, or the return to work, each of which is a programme with a frequency and a review rather than advice to take it easy.
The other thing the months contain is fatigue, and it is worth naming because it is the item families interpret as a failure of the person rather than a consequence of the illness. A recovery measured in months rather than weeks is normal here, and a plan that says so is doing something useful.
Where the honest answer is that no further treatment would change the outcome, that is a conclusion and it should be a written one with a review date attached — not an abandonment, and not a deferral that nobody revisits. What this costs and what a stay involves is set out in the practical questions.